Suppr超能文献

基于碳酸钙和聚乳酸的纳米和微米载体用于口服递送 siRNA 的研究。

An investigation of nano- and micron-sized carriers based on calcium carbonate and polylactic acid for oral administration of siRNA.

机构信息

Laboratory of nano- and microencapsulation of biologically active substances, Peter The Great St. Petersburg Polytechnic University, St. Petersburg, Russia.

International Research and Education Centre for Physics of Nanostructures, ITMO University, St. Petersburg, Russia.

出版信息

Expert Opin Drug Deliv. 2024 Aug;21(8):1279-1295. doi: 10.1080/17425247.2024.2393244. Epub 2024 Aug 21.

Abstract

BACKGROUND

Oral delivery of small interfering RNAs (siRNAs) draws significant attention, but the gastrointestinal tract (GIT) has many biological barriers that limit the drugs' bioavailability. The aim of this work was to investigate the potential of micro- and nano-sized CaCO and PLA carriers for oral delivery of siRNA and reveal a relationship between the physicochemical features of these carriers and their biodistribution.

RESEARCH DESIGN AND METHODS

stability of carriers was investigated in simulated gastric and intestinal fluids. Toxicity and cellular uptake were investigated on Caco-2 cells. The biodistribution profiles of the developed CaCO and PLA carriers were examined using different visualization methods, including SPECT, fluorescence imaging, radiometry, and histological analysis. The delivery efficiency of siRNA loaded carriers was investigated both and .

RESULTS

Micro-sized carriers were accumulated in the stomach and later localized in the colon tissues. The nanoscale particles (100-250 nm) were distributed in the colon tissues. nPLA was also detected in small intestine. The developed carriers can prevent siRNA from premature degradation in GIT media.

CONCLUSION

Our results reveal how the physicochemical properties of the particles, including their size and material type can affect their biodistribution profile and oral delivery of siRNA.

摘要

背景

口服递送小干扰 RNA(siRNA)引起了广泛关注,但胃肠道(GIT)存在许多生物屏障,限制了药物的生物利用度。本研究旨在探讨微纳米级 CaCO 和 PLA 载体在 siRNA 口服递送中的应用潜力,并揭示这些载体的理化特性与其体内分布之间的关系。

研究设计与方法

在模拟胃液和肠液中研究了载体的稳定性。在 Caco-2 细胞上研究了载体的毒性和细胞摄取。采用 SPECT、荧光成像、放射性测量和组织学分析等不同可视化方法研究了开发的 CaCO 和 PLA 载体的体内分布特征。通过体内和体外实验研究了负载 siRNA 的载体的递送效率。

结果

微载体在胃中积累,随后定位于结肠组织中。纳米级颗粒(100-250nm)分布在结肠组织中。nPLA 也在小肠中被检测到。所开发的载体可以防止 siRNA 在 GIT 介质中过早降解。

结论

我们的结果揭示了颗粒的理化性质,包括其大小和材料类型如何影响其体内分布特征和 siRNA 的口服递送。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验